Details for New Drug Application (NDA): 076484
✉ Email this page to a colleague
The generic ingredient in CIPROFLOXACIN is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 076484
Tradename: | CIPROFLOXACIN |
Applicant: | Fresenius Kabi Usa |
Ingredient: | ciprofloxacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076484
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/20ML (10MG/ML) | ||||
Approval Date: | Aug 28, 2006 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/40ML (10MG/ML) | ||||
Approval Date: | Aug 28, 2006 | TE: | RLD: | No |
Complete Access Available with Subscription